These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7684628)

  • 1. Effect of lodoxamide on in vitro and in vivo conjunctival immediate hypersensitivity responses in rats.
    Yanni JM; Weimer LK; Glaser RL; Lang LS; Robertson SM; Spellman JM
    Int Arch Allergy Immunol; 1993; 101(1):102-6. PubMed ID: 7684628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent.
    Yanni JM; Stephens DJ; Miller ST; Weimer LK; Graff G; Parnell D; Lang LS; Spellman JM; Brady MT; Gamache DA
    J Ocul Pharmacol Ther; 1996; 12(4):389-400. PubMed ID: 8951675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiallergic activity of topical lodoxamide on in vivo and in vitro models.
    Ciprandi G; Buscaglia S; Catrullo A; Paolieri F; Riccio AM; Fiorino N; Canonica GW
    Allergy; 1996 Dec; 51(12):946-51. PubMed ID: 9020426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital.
    Adefule-Ositelu AO; Onakoya AO; Olasimbo OO; Adefule AK
    Niger Postgrad Med J; 2006 Mar; 13(1):35-40. PubMed ID: 16633377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis.
    Verin P; Allewaert R; Joyaux JC; Piozzi E; Koliopoulos J; Bloch-Michel E;
    Eur J Ophthalmol; 2001; 11(2):120-5. PubMed ID: 11456011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
    Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
    Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ketotifen 0.025% and lodoxamide 0.1% on eosinophil infiltration into the guinea pig conjunctiva in a model of allergic conjunctivitis.
    Schoch C
    J Ocul Pharmacol Ther; 2003 Apr; 19(2):153-9. PubMed ID: 12804060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis.
    Bonini S; Schiavone M; Bonini S; Magrini L; Lischetti P; Lambiase A; Bucci MG
    Ophthalmology; 1997 May; 104(5):849-53. PubMed ID: 9160033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of iodoxamide ethyl on allergy skin tests.
    Frigas E; Reed CE
    J Allergy Clin Immunol; 1980 Apr; 65(4):257-62. PubMed ID: 7358942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells.
    Yanni JM; Miller ST; Gamache DA; Spellman JM; Xu S; Sharif NA
    Ann Allergy Asthma Immunol; 1997 Dec; 79(6):541-5. PubMed ID: 9433371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro effects of antiallergic eyedrops on complement activation induced by particulate matter].
    Blondin C; Cholley B; Haeffner-Cavaillon N; Goldschmidt P
    J Fr Ophtalmol; 2003 Apr; 26(4):328-36. PubMed ID: 12843888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tear histamine and histaminase during the early (EPR) and late (LPR) phases of the allergic reaction and the effects of lodoxamide.
    Leonardi AA; Smith LM; Fregona IA; Salmaso M; Secchi AG
    Eur J Ophthalmol; 1996; 6(2):106-12. PubMed ID: 8823580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis.
    Grutzmacher RD; Foster RS; Feiler LS
    Am J Ophthalmol; 1995 Sep; 120(3):400-2. PubMed ID: 7661218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lodoxamide in vernal keratoconjunctivitis.
    Lee S; Allard TR
    Ann Pharmacother; 1996 May; 30(5):535-7. PubMed ID: 8740338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic microvascular regulatory mechanisms. IV. Effect of lodoxamide tromethamine and arterenol-HCl on vascular responses evoked by compound 48/80.
    Reilly FD; Dimlich RV
    Microcirc Endothelium Lymphatics; 1984 Feb; 1(1):87-106. PubMed ID: 6152810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of non-steroidal antiallergic eyedrops on the complement-mediated histamine release from human cells.
    Goldschmidt P; Couturier C; Haeffner-Cavaillon N; Kazatchkine M; Herman D
    Ocul Immunol Inflamm; 1997 Mar; 5(1):11-7. PubMed ID: 9145688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of lodoxamide on eosinophil activation.
    Capron M; Loiseau S; Papin JP; Robertson S; Capron A
    Int Arch Allergy Immunol; 1998 Jun; 116(2):140-6. PubMed ID: 9652307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lodoxamide treatment of allergic conjunctivitis.
    Cerqueti PM; Ricca V; Tosca MA; Buscaglia S; Ciprandi G
    Int Arch Allergy Immunol; 1994 Oct; 105(2):185-9. PubMed ID: 7920019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of lodoxamide 0.1% versus N-acetyl aspartyl glutamic acid 6% ophthalmic solutions in patients with vernal keratoconjunctivitis.
    Gündüz K; Uçakhan O; Budak K; Eryilmaz T; Ozkan M
    Ophthalmic Res; 1996; 28(2):80-7. PubMed ID: 8792357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA.
    Denis D; Bloch-Michel E; Verin P; Sebastiani A; Tazartes M; Helleboid L; Di Giovanni A; Lecorvec M
    Br J Ophthalmol; 1998 Oct; 82(10):1135-8. PubMed ID: 9924299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.